2023
Sidhu, J. K., Siggins, M. K., Liew, F., Russell, C. D., Uruchurtu, A. S. S., Davis, C., . . . ISARIC4C investigators. (2023). Delayed mucosal anti-viral responses despite robust peripheral inflammation in fatal COVID-19.. The Journal of infectious diseases, jiad590. doi:10.1093/infdis/jiad590DOI: 10.1093/infdis/jiad590
Natural immune boosting can cause synchrony in susceptibility and outbreaks of respiratory infections with rapidly waning immunity (Preprint)
DOI: 10.1101/2023.11.23.23298952
Neale, I., Ali, M., Kronsteiner, B., Longet, S., Abraham, P., Deeks, A. S., . . . PITCH Consortium. (2023). CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study.. mBio, e0121223. doi:10.1128/mbio.01212-23DOI: 10.1128/mbio.01212-23
Turtle, L., & Subramaniam, K. (2023). Modified vaccinia Ankara-Bavarian Nordic vaccine against mpox in children. LANCET INFECTIOUS DISEASES, 23(9), 989-990. doi:10.1016/S1473-3099(23)00345-6DOI: 10.1016/S1473-3099(23)00345-6
Hornsby, H., Nicols, A. R., Longet, S., Liu, C., Tomic, A., Angyal, A., . . . de Silva, T. I. (2023). Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history.. Nature communications, 14(1), 5065. doi:10.1038/s41467-023-40592-4DOI: 10.1038/s41467-023-40592-4
Yang, H., Sun, H., Brackenridge, S., Zhuang, X., Wing, P. A. C., Quastel, M., . . . McMichael, A. J. (2023). HLA-E-restricted SARS-CoV-2-specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation. SCIENCE IMMUNOLOGY, 8(84). doi:10.1126/sciimmunol.abl8881DOI: 10.1126/sciimmunol.abl8881
Bharucha, T., Gangadharan, B., Kumar, A., Myall, A. C., Ayhan, N., Pastorino, B., . . . SEAe, C. (2023). Deep Proteomics Network and Machine Learning Analysis of Human Cerebrospinal Fluid in Japanese Encephalitis Virus Infection. JOURNAL OF PROTEOME RESEARCH, 22(6), 1614-1629. doi:10.1021/acs.jproteome.2c00563DOI: 10.1021/acs.jproteome.2c00563
You, L., Chen, J., Cheng, Y., Li, Y., Chen, Y. -Q., Ying, T., . . . Yu, H. (2023). Antibody signatures in hospitalized hand, foot and mouth disease patients with acute enterovirus A71 infection. PLOS PATHOGENS, 19(6). doi:10.1371/journal.ppat.1011420DOI: 10.1371/journal.ppat.1011420
Cho, S. -M., White, N., Premraj, L., Battaglini, D., Fanning, J., Suen, J., . . . ISARIC Clinical Characterisation Group. (2023). Neurological manifestations of COVID-19 in adults and children.. Brain : a journal of neurology, 146(4), 1648-1661. doi:10.1093/brain/awac332DOI: 10.1093/brain/awac332
Zhou, Y., Zhou, C., Wang, K., Qiu, Q., Cheng, Y., Li, Y., . . . Yu, H. (2023). Diagnostic performance of different specimens in detecting enterovirus A71 in children with hand, foot and mouth disease. VIROLOGICA SINICA, 38(2), 268-275. doi:10.1016/j.virs.2022.11.004DOI: 10.1016/j.virs.2022.11.004
Ho, A., Orton, R., Tayler, R., Asamaphan, P., Herder, V., Davis, C., . . . Thomson, E. C. (2023). Adeno-associated virus 2 infection in children with non-A-E hepatitis.. Nature. doi:10.1038/s41586-023-05948-2DOI: 10.1038/s41586-023-05948-2
Goldswain, H., Dong, X., Penrice-Randal, R., Alruwaili, M., Shawli, G. T., Prince, T., . . . Hiscox, J. A. (2023). The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection.. Genome biology, 24(1), 47. doi:10.1186/s13059-023-02881-5DOI: 10.1186/s13059-023-02881-5
Moore, S., Kronsteiner, B., Longet, S., Adele, S., Deeks, A., Liu, C., . . . Consortium, P. I. T. C. H. (2023). Evolution of Long-Term Hybrid Immunity in Healthcare Workers after Different Covid-19 Vaccination Regimens: A Longitudinal Observational Cohort Study. Med. doi:10.1016/j.medj.2023.02.004DOI: 10.1016/j.medj.2023.02.004
Moore, S. C., Kronsteiner, B., Longet, S., Adele, S., Deeks, A. S., Liu, C., . . . PITCH, C. (2023). Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens. MED, 4(3), 191-+. doi:10.1016/j.medj.2023.02.004DOI: 10.1016/j.medj.2023.02.004
Kartsonaki, C., Baillie, J. K., Barrio, N. G., Baruch, J., Beane, A., Blumberg, L., . . . ISARIC Clinical Characterisation Group. (2023). Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19.. International journal of epidemiology, dyad012. doi:10.1093/ije/dyad012DOI: 10.1093/ije/dyad012
Greenland-Bews, C., Byrne, R. L. L., Owen, S. I. I., Watkins, R. L. L., Bengey, D., Buist, K., . . . Adams, E. R. R. (2023). Evaluation of eight lateral flow tests for the detection of anti-SARS-CoV-2 antibodies in a vaccinated population. BMC INFECTIOUS DISEASES, 23(1). doi:10.1186/s12879-023-08033-1DOI: 10.1186/s12879-023-08033-1
Turtle, L., Thorpe, M., Drake, T. M., Swets, M., Palmieri, C., Russell, C. D., . . . Docherty, A. B. (2023). Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study.. PLoS medicine, 20(1), e1004086. doi:10.1371/journal.pmed.1004086DOI: 10.1371/journal.pmed.1004086
Jay, C., Ratcliff, J., Turtle, L., Goulder, P., & Klenerman, P. (2023). Exposed seronegative: Cellular immune responses to SARS-CoV-2 in the absence of seroconversion. FRONTIERS IN IMMUNOLOGY, 14. doi:10.3389/fimmu.2023.1092910DOI: 10.3389/fimmu.2023.1092910
Lie-Andersen, O., Hubbe, M. L., Subramaniam, K., Steen-Jensen, D., Bergmann, A. C., Justesen, D., . . . Hansen, M. (2023). Impact of peptide:HLA complex stability for the identification of SARS-CoV-2-specific CD8<SUP>+</SUP>T cells. FRONTIERS IN IMMUNOLOGY, 14. doi:10.3389/fimmu.2023.1151659DOI: 10.3389/fimmu.2023.1151659
Parker, E., Thomas, J., Roper, K. J., Ijaz, S., Edwards, T., Marchesin, F., . . . Pollakis, G. (2023). SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective study. FRONTIERS IN IMMUNOLOGY, 14. doi:10.3389/fimmu.2023.1146702DOI: 10.3389/fimmu.2023.1146702
Liew, F., Talwar, S., Cross, A., Willett, B. J., Scott, S., Logan, N., . . . Openshaw, P. J. M. (2023). SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination. EBIOMEDICINE, 87. doi:10.1016/j.ebiom.2022.104402DOI: 10.1016/j.ebiom.2022.104402
2022
Green, M. A., Hungerford, D. J., Hughes, D. M., Garcia-Finana, M., Turtle, L., Cheyne, C., . . . Buchan, I. (2022). Changing patterns of SARS-CoV-2 infection through Delta and Omicron waves by vaccination status, previous infection and neighbourhood deprivation: a cohort analysis of 2.7 M people. BMC INFECTIOUS DISEASES, 22(1). doi:10.1186/s12879-022-07878-2DOI: 10.1186/s12879-022-07878-2
Alam, A. M., Gillespie, C. S., Goodall, J., Damodar, T., Turtle, L., Vasanthapuram, R., . . . Michael, B. D. (2022). Neurological manifestations of scrub typhus infection: A systematic review and meta-analysis of clinical features and case fatality. PLOS NEGLECTED TROPICAL DISEASES, 16(11). doi:10.1371/journal.pntd.0010952DOI: 10.1371/journal.pntd.0010952
Vink, E., Davis, C., MacLean, A., Pascall, D., McDonald, S. E., Gunson, R., . . . Ho, A. (2022). Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study. OPEN FORUM INFECTIOUS DISEASES, 9(11). doi:10.1093/ofid/ofac531DOI: 10.1093/ofid/ofac531
Kotanidis, C. P., Xie, C., Alexander, D., Rodrigues, J. C. L., Burnham, K., Mentzer, A., . . . Antoniades, C. (2022). Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19. LANCET DIGITAL HEALTH, 4(10), E705-E716. doi:10.1016/S2589-7500(22)00132-7DOI: 10.1016/S2589-7500(22)00132-7
Willett, B. J., Grove, J., MacLean, O. A., Wilkie, C., De Lorenzo, G., Furnon, W., . . . Thomson, E. C. (2022). SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway (vol 7, pg 1161, 2022). NATURE MICROBIOLOGY, 7(10), 1709. doi:10.1038/s41564-022-01241-6DOI: 10.1038/s41564-022-01241-6
Siggins, M. K., Davies, K., Fellows, R., Thwaites, R. S., Baillie, J. K., Semple, M. G., . . . ISARIC4C Investigators. (2022). Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19.. Immunology. doi:10.1111/imm.13585DOI: 10.1111/imm.13585
Wysocki, O., Zhou, C., Rogado, J., Huddar, P., Shotton, R., Tivey, A., . . . Co-Care, E. S. M. O. (2022). An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves. Cancers, 14(16). doi:10.3390/cancers14163931DOI: 10.3390/cancers14163931
Reyes, L. F., Murthy, S., Garcia-Gallo, E., Merson, L., Ibanez-Prada, E. D., Rello, J., . . . Olliaro, P. L. (2022). Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study. CRITICAL CARE, 26(1). doi:10.1186/s13054-022-04155-1DOI: 10.1186/s13054-022-04155-1
Longet, S., Hargreaves, A., Healy, S., Brown, R., Hornsby, H. R., Meardon, N., . . . Carroll, M. W. (2022). mRNA vaccination drives differential mucosal neutralizing antibody profiles in naive and SARS-CoV-2 previously-infected individuals. FRONTIERS IN IMMUNOLOGY, 13. doi:10.3389/fimmu.2022.953949DOI: 10.3389/fimmu.2022.953949
Evans, R. A., Leavy, O. C., Richardson, M., Elneima, O., McAuley, H. J. C., Shikotra, A., . . . Brightling, C. E. (2022). Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. LANCET RESPIRATORY MEDICINE, 10(8), 761-775. doi:10.1016/S2213-2600(22)00127-8DOI: 10.1016/S2213-2600(22)00127-8
Adler, H., Gould, S., Hine, P., Snell, L. B., Wong, W., Houlihan, C. F., . . . Price, N. M. (2022). Clinical features and management of human monkeypox: a retrospective observational study in the UK. LANCET INFECTIOUS DISEASES, 22(8), 1153-1162. doi:10.1016/S1473-3099(22)00228-6DOI: 10.1016/S1473-3099(22)00228-6
Ijaz, S., Dicks, S., Jegatheesan, K., Parker, E., Katsanovskaja, K., Vink, E., . . . Tedder, R. S. (2022). Mapping of SARS-CoV-2 IgM and IgG in gingival crevicular fluid: Antibody dynamics and linkage to severity of COVID-19 in hospital inpatients. JOURNAL OF INFECTION, 85(2), 152-160. doi:10.1016/j.jinf.2022.05.033DOI: 10.1016/j.jinf.2022.05.033
Willett, B. J., Grove, J., MacLean, O. A., Wilkie, C., De Lorenzo, G., Furnon, W., . . . Thomson, E. C. (2022). SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. NATURE MICROBIOLOGY, 7(8), 1161-+. doi:10.1038/s41564-022-01143-7DOI: 10.1038/s41564-022-01143-7
Garcia-Gallo, E., Merson, L., Kennon, K., Kelly, S., Citarella, B. W., Fryer, D. V., . . . Reyes, L. F. (2022). ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19. SCIENTIFIC DATA, 9(1). doi:10.1038/s41597-022-01534-9DOI: 10.1038/s41597-022-01534-9
Eales, O., Page, A. J., de Oliveira Martins, L., Wang, H., Bodinier, B., Haw, D., . . . Elliott, P. (2022). SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2. BMC Infectious Diseases, 22(1). doi:10.1186/s12879-022-07628-4DOI: 10.1186/s12879-022-07628-4
Phillips, E., Adele, S., Malone, T., Deeks, A., Stafford, L., Dobson, S. L., . . . Dunachie, S. J. (2022). Comparison of two T-cell assays to evaluate T-cell responses to SARS-CoV-2 following vaccination in naive and convalescent healthcare workers. CLINICAL AND EXPERIMENTAL IMMUNOLOGY. doi:10.1093/cei/uxac042DOI: 10.1093/cei/uxac042
Nickbakhsh, S., Hughes, J., Christofidis, N., Griffiths, E., Shaaban, S., Enright, J., . . . Smith-Palmer, A. (2022). Genomic epidemiology of SARS-CoV-2 in a university outbreak setting and implications for public health planning. Scientific Reports, 12(1). doi:10.1038/s41598-022-15661-1DOI: 10.1038/s41598-022-15661-1
Kousathanas, A., Pairo-Castineira, E., Rawlik, K., Stuckey, A., Odhams, C. A., Walker, S., . . . Baillie, J. K. (2022). Whole-genome sequencing reveals host factors underlying critical COVID-19. NATURE, 607(7917), 97-+. doi:10.1038/s41586-022-04576-6DOI: 10.1038/s41586-022-04576-6
Flavivirus cross-reactivity would explain the apparent findings of Japanese encephalitis virus infection in Nigeria. (Journal article)
Bharucha, T., Zitzmann, N., Newton, P., Dubot-Pérès, A., & Turtle, L. (2022). Flavivirus cross-reactivity would explain the apparent findings of Japanese encephalitis virus infection in Nigeria.. Journal of immunoassay & immunochemistry, 43(4), 463-465. doi:10.1080/15321819.2022.2039184DOI: 10.1080/15321819.2022.2039184
Analysis of SARS-CoV-2 in Nasopharyngeal Samples from Patients with COVID-19 Illustrates Population Variation and Diverse Phenotypes, Placing the Growth Properties of Variants of Concern in Context with Other Lineages (Journal article)
Prince, T., Dong, X., Penrice-Randal, R., Randle, N., Hartley, C., Goldswain, H., . . . Hiscox, J. A. (2022). Analysis of SARS-CoV-2 in Nasopharyngeal Samples from Patients with COVID-19 Illustrates Population Variation and Diverse Phenotypes, Placing the Growth Properties of Variants of Concern in Context with Other Lineages. MSPHERE, 7(3). doi:10.1128/msphere.00913-21DOI: 10.1128/msphere.00913-21
Klaser, K., Molteni, E., Graham, M., Canas, L. S., Osterdahl, M. F., Antonelli, M., . . . Duncan, E. L. (2022). COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study. SCIENTIFIC REPORTS, 12(1). doi:10.1038/s41598-022-14016-0DOI: 10.1038/s41598-022-14016-0
Pichl, T., Wedderburn, C. J., Hoskote, C., Turtle, L., & Bharucha, T. (2022). A systematic review of brain imaging findings in neurological infection with Japanese encephalitis virus compared with Dengue virus.. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 119, 102-110. doi:10.1016/j.ijid.2022.03.010DOI: 10.1016/j.ijid.2022.03.010
Dong, X., Penrice-Randal, R., Goldswain, H., Prince, T., Randle, N., Donovan-Banfield, I., . . . Hiscox, J. A. (2022). Analysis of SARS-CoV-2 known and novel subgenomic mRNAs in cell culture, animal model, and clinical samples using LeTRS, a bioinformatic tool to identify unique sequence identifiers. GIGASCIENCE, 11. doi:10.1093/gigascience/giac045DOI: 10.1093/gigascience/giac045
Lee, R. J., Wysocki, O., Zhou, C., Shotton, R., Tivey, A., Lever, L., . . . Armstrong, A. C. (2022). Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital.. JCO clinical cancer informatics, 6, e2100177. doi:10.1200/cci.21.00177DOI: 10.1200/cci.21.00177
Correia, G. D. S., Takis, P. G., Sands, C. J., Kowalka, A. M., Tan, T., Turtle, L., . . . Lewis, M. R. (2022). <SUP>1</SUP>H NMR Signals from Urine Excreted Protein Are a Source of Bias in Probabilistic Quotient Normalization. ANALYTICAL CHEMISTRY, 94(19), 6919-6923. doi:10.1021/acs.analchem.2c00466DOI: 10.1021/acs.analchem.2c00466
Khoury, E., Nevitt, S., Madsen, W. R., Turtle, L., Davies, G., & Palmieri, C. (2022). Differences in Outcomes and Factors Associated With Mortality Among Patients With SARS-CoV-2 Infection and Cancer Compared With Those Without Cancer A Systematic Review and Meta-analysis. JAMA NETWORK OPEN, 5(5). doi:10.1001/jamanetworkopen.2022.10880DOI: 10.1001/jamanetworkopen.2022.10880
Relph, K. A., Russell, C. D., Fairfield, C. J., Turtle, L., de Silva, T. I., Siggins, M. K., . . . Young, P. (2022). Procalcitonin Is Not a Reliable Biomarker of Bacterial Coinfection in People With Coronavirus Disease 2019 Undergoing Microbiological Investigation at the Time of Hospital Admission. Open Forum Infectious Diseases, 9(5). doi:10.1093/ofid/ofac179DOI: 10.1093/ofid/ofac179
SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients (Journal article)
Shankar, S., Beckett, J., Tipton, T., Ogbe, A., Kasanyinga, M., Dold, C., . . . Klenerman, P. (2022). SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 33(5), 883-887. doi:10.1681/ASN.2021121587DOI: 10.1681/ASN.2021121587
Swann, O. V., Pollock, L., Holden, K. A., Munro, A. P. S., Bennett, A., Williams, T. C., . . . Investigators, I. (2022). Comparison of UK paediatric SARS-CoV-2 admissions across the first and second pandemic waves. PEDIATRIC RESEARCH. doi:10.1038/s41390-022-02052-5DOI: 10.1038/s41390-022-02052-5
Narhi, F., Moonesinghe, S. R., Shenkin, S. D., Drake, T. M., Mulholland, R. H., Donegan, C., . . . Docherty, A. B. (2022). Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study. LANCET DIGITAL HEALTH, 4(4). Retrieved from https://www.webofscience.com/
Tomic, A., Skelly, D. T., Ogbe, A., O'Connor, D., Pace, M., Adland, E., . . . Dunachie, S. J. (2022). Divergent trajectories of antiviral memory after SARS-CoV-2 infection. NATURE COMMUNICATIONS, 13(1). doi:10.1038/s41467-022-28898-1DOI: 10.1038/s41467-022-28898-1
Ahern, D. J., Ai, Z., Ainsworth, M., Allan, C., Allcock, A., Angus, B., . . . Zurke, Y. -X. (2022). A blood atlas of COVID-19 defines hallmarks of disease severity and specificity. CELL, 185(5), 916-+. doi:10.1016/j.cell.2022.01.012DOI: 10.1016/j.cell.2022.01.012
Aggarwal, D., Page, A. J., Schaefer, U., Savva, G. M., Myers, R., Volz, E., . . . Harrison, E. M. (2022). Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission. NATURE COMMUNICATIONS, 13(1). doi:10.1038/s41467-022-28371-zDOI: 10.1038/s41467-022-28371-z
Egan, C., Turtle, L., Thorpe, M., Harrison, E. M., Semple, M. G., & Docherty, A. B. (2022). Hospital admission for symptomatic COVID-19 and impact of vaccination: analysis of linked data from the Coronavirus Clinical Information Network and the National Immunisation Management Service. ANAESTHESIA. doi:10.1111/anae.15677DOI: 10.1111/anae.15677
Aggarwal, D., Warne, B., Jahun, A. S., Hamilton, W. L., Fieldman, T., du Plessis, L., . . . Consor, C. G. U. K. C. O. G. -U. K. (2022). Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission. NATURE COMMUNICATIONS, 13(1). doi:10.1038/s41467-021-27942-wDOI: 10.1038/s41467-021-27942-w
Dejnirattisai, W., Huo, J., Zhou, D., Zahradník, J., Supasa, P., Liu, C., . . . Screaton, G. R. (2022). SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses.. Cell, 185(3), 467-484.e15. doi:10.1016/j.cell.2021.12.046DOI: 10.1016/j.cell.2021.12.046
Bharucha, T., Cleary, B., Farmiloe, A., Sutton, E., Hayati, H., Kirkwood, P., . . . Turtle, L. (2022). Mouse models of Japanese encephalitis virus infection: A systematic review and meta-analysis using a meta-regression approach.. PLoS neglected tropical diseases, 16(2), e0010116. doi:10.1371/journal.pntd.0010116DOI: 10.1371/journal.pntd.0010116
Anderson, E. R., Prince, T., Turtle, L., Hughes, G. L., & Patterson, E. I. (2022). Methods of SARS-CoV-2 Inactivation.. Methods in molecular biology (Clifton, N.J.), 2452, 465-473. doi:10.1007/978-1-0716-2111-0_25DOI: 10.1007/978-1-0716-2111-0_25
Knight, S. R., Gupta, R. K., Ho, A., Pius, R., Buchan, I., Carson, G., . . . Harrison, E. M. (2022). Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol. THORAX, 77(6), 606-615. doi:10.1136/thoraxjnl-2021-217629DOI: 10.1136/thoraxjnl-2021-217629
Angyal, A., Longet, S., Moore, S. C., Payne, R. P., Harding, A., Tipton, T., . . . de, S. T. I. (2022). T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study. LANCET MICROBE, 3(1), E21-E31. doi:10.1016/S2666-5247(21)00275-5DOI: 10.1016/S2666-5247(21)00275-5
2021
Niemi, M. E. K., Karjalainen, J., Daly, M., Ganna, A., Mehtonen, J., Cordioli, M., . . . Dopazo, X. (2021). Mapping the human genetic architecture of COVID-19. NATURE, 600(7889), 472-+. doi:10.1038/s41586-021-03767-xDOI: 10.1038/s41586-021-03767-x
The value of open-source clinical science in pandemic response: lessons from ISARIC (Journal article)
The value of open-source clinical science in pandemic response: lessons from ISARIC (2021). LANCET INFECTIOUS DISEASES, 21(12), 1623-1624. doi:10.1016/S1473-3099(21)00565-XDOI: 10.1016/S1473-3099(21)00565-X
Antiviral activity of Molnupiravir precursor NHC against SARS-CoV-2 Variants of Concern (VOCs) and implications for the therapeutic window and resistance (Preprint)
DOI: 10.1101/2021.11.23.469695
de, S. T. I., Liu, G., Lindsey, B. B., Dong, D., Moore, S. C., Hsu, N. S., . . . Dong, T. (2021). The impact of viral mutations on recognition by SARS-CoV-2 specific T cells. ISCIENCE, 24(11). doi:10.1016/j.isci.2021.103353DOI: 10.1016/j.isci.2021.103353
Griffiths, M. (2021). A Systematic Evaluation of IgM and IgG Antibody Assay Accuracy in Diagnosing Acute Zika Virus Infection in Brazil: Lessons Relevant to Emerging Infections. Journal of Clinical Microbiology.
Payne, R. P., Longet, S., Austin, J. A., Skelly, D. T., Dejnirattisai, W., Adele, S., . . . Dunachie, S. (2021). Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine. CELL, 184(23), 5699-+. doi:10.1016/j.cell.2021.10.011DOI: 10.1016/j.cell.2021.10.011
Evans, R. A., McAuley, H., Harrison, E. M., Shikotra, A., Singapuri, A., Sereno, M., . . . Brightling, C. E. (2021). Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. LANCET RESPIRATORY MEDICINE, 9(11), 1275-1287. doi:10.1016/S2213-2600(21)00383-0DOI: 10.1016/S2213-2600(21)00383-0
Wickenhagen, A., Sugrue, E., Lytras, S., Kuchi, S., Noerenberg, M., Turnbull, M. L., . . . Wilson, S. J. (2021). A prenylated dsRNA sensor protects against severe COVID-19. SCIENCE, 374(6567). doi:10.1126/science.abj3624DOI: 10.1126/science.abj3624
Shrwani, K., Sharma, R., Krishnan, M., Jones, T., Mayora-Neto, M., Cantoni, D., . . . Zhang, Q. (2021). Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples. JOURNAL OF INFECTIOUS DISEASES, 224(8), 1305-1315. doi:10.1093/infdis/jiab333DOI: 10.1093/infdis/jiab333
Wilder-Smith, A., Brickley, E. B., Ximenes, R. A. D. A., Miranda-Filho, D. D. B., Turchi Martelli, C. M., Solomon, T., . . . Preet, R. (2021). The legacy of ZikaPLAN: a transnational research consortium addressing Zika. GLOBAL HEALTH ACTION, 14. doi:10.1080/16549716.2021.2008139DOI: 10.1080/16549716.2021.2008139
Hurst, E. A., Mellanby, R. J., Handel, I., Griffith, D. M., Rossi, A. G., Walsh, T. S., . . . Russell, C. D. (2021). Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study. BMJ OPEN, 11(10). doi:10.1136/bmjopen-2021-055435DOI: 10.1136/bmjopen-2021-055435
Abdukahil, S. A., Abe, R., Abel, L., Absil, L., Acker, A., Adachi, S., . . . Zucman, D. (2021). COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study. INFECTION, 49(5), 889-905. doi:10.1007/s15010-021-01599-5DOI: 10.1007/s15010-021-01599-5
Read, J. M., Green, C. A., Harrison, E. M., Docherty, A. B., Funk, S., Harrison, J., . . . Semple, M. G. (2021). Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave. LANCET, 398(10305), 1037-1038. doi:10.1016/S0140-6736(21)01786-4DOI: 10.1016/S0140-6736(21)01786-4
Shaw, R. J., Abrams, S. T., Austin, J., Taylor, J. M., Lane, S., Dutt, T., . . . Toh, C. -H. (2021). Circulating histones play a central role in COVID-19-associated coagulopathy and mortality. HAEMATOLOGICA, 106(9), 2493-2498. doi:10.3324/haematol.2021.278492DOI: 10.3324/haematol.2021.278492
Palmieri, C., Turtle, L., Drake, T., Harrison, E., Docherty, A., Greenhalf, B., . . . Semple, M. M. G. (2021). LBA60 Prospective data of >20,000 hospitalised patients with cancer and COVID-19 derived from the International Severe Acute Respiratory and emerging Infections Consortium WHO Coronavirus Clinical Characterisation Consortium: CCP-CANCER UK. In Annals of oncology : official journal of the European Society for Medical Oncology Vol. 32 (pp. S1337).
Sigfrid, L., Drake, T. M., Pauley, E., Jesudason, E. C., Olliaro, P., Lim, W. S., . . . Scott, J. T. (2021). Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. LANCET REGIONAL HEALTH-EUROPE, 8. doi:10.1016/j.lanepe.2021.100186DOI: 10.1016/j.lanepe.2021.100186
Twohig, K. A., Nyberg, T., Zaidi, A., Thelwall, S., Sinnathamby, M. A., Aliabadi, S., . . . COVID-19 Genomics UK (COG-UK) consortium. (2021). Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.. The Lancet. Infectious diseases, 22(1), 35-42. doi:10.1016/s1473-3099(21)00475-8DOI: 10.1016/s1473-3099(21)00475-8
Skelly, D. T., Harding, A. C., Gilbert-Jaramillo, J., Knight, M. L., Longet, S., Brown, A., . . . James, W. S. (2021). Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern. NATURE COMMUNICATIONS, 12(1). doi:10.1038/s41467-021-25167-5DOI: 10.1038/s41467-021-25167-5
Vaselli, N. M., Setiabudi, W., Subramaniam, K., Adams, E. R., Turtle, L., Iturriza-Gomara, M., . . . Hungerford, D. (2021). Investigation of SARS-CoV-2 faecal shedding in the community: a prospective household cohort study (COVID-LIV) in the UK. BMC INFECTIOUS DISEASES, 21(1). doi:10.1186/s12879-021-06443-7DOI: 10.1186/s12879-021-06443-7
Russell, C. D., Fairfield, C. J., Drake, T. M., Turtle, L., Seaton, R. A., Wootton, D. G., . . . Ho, A. (2021). Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study. LANCET MICROBE, 2(8), E354-E365. doi:10.1016/S2666-5247(21)00090-2DOI: 10.1016/S2666-5247(21)00090-2
Drake, T. M., Riad, A. M., Fairfield, C. J., Egan, C., Knight, S. R., Pius, R., . . . Semple, M. G. (2021). Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. LANCET, 398(10296), 223-237. Retrieved from https://www.webofscience.com/
Docherty, A., Mulholland, R., Lone, N. I., Cheyne, C., De Angelis, D., Diaz-Ordaz, K., . . . Semple, M. (2021). Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK. LANCET RESPIRATORY MEDICINE, 9(7), 773-785. doi:10.1016/S2213-2600(21)00175-2DOI: 10.1016/S2213-2600(21)00175-2
Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study. (Journal article)
Drake, T. M., Fairfield, C. J., Pius, R., Knight, S. R., Norman, L., Girvan, M., . . . ISARIC4C Investigators. (2021). Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study.. The Lancet. Rheumatology, 3(7), e498-e506. doi:10.1016/s2665-9913(21)00104-1DOI: 10.1016/s2665-9913(21)00104-1
Yates, T., Zaccardi, F., Islam, N., Razieh, C., Gillies, C. L., Lawson, C. A., . . . Khunti, K. (2021). Obesity, Ethnicity, and Risk of Critical Care, Mechanical Ventilation, and Mortality in Patients Admitted to Hospital with COVID-19: Analysis of the ISARIC CCP-UK Cohort. OBESITY, 29(7), 1223-1230. doi:10.1002/oby.23178DOI: 10.1002/oby.23178
Bloom, C. I., Drake, T. M., Docherty, A. B., Lipworth, B. J., Johnston, S. L., Nguyen-Van-Tam, J. S., . . . Openshaw, P. J. M. (2021). Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19 a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK. LANCET RESPIRATORY MEDICINE, 9(7), 699-711. doi:10.1016/S2213-2600(21)00013-8DOI: 10.1016/S2213-2600(21)00013-8
Meng, B., Kemp, S. A., Papa, G., Datir, R., Ferreira, I. A. T. M., Marelli, S., . . . Gupta, R. K. (2021). Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7. CELL REPORTS, 35(13). doi:10.1016/j.celrep.2021.109292DOI: 10.1016/j.celrep.2021.109292
Leclerc, Q. J., Fuller, N. M., Keogh, R. H., Diaz-Ordaz, K., Sekula, R., Semple, M. G., . . . Knight, G. M. (2021). Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England. BMC HEALTH SERVICES RESEARCH, 21(1). doi:10.1186/s12913-021-06509-xDOI: 10.1186/s12913-021-06509-x
Qiu, Q., Zhou, J., Cheng, Y., Zhou, Y., Liang, L., Cui, P., . . . Yu, H. (2021). Kinetics of the neutralising antibody response in patients with hand, foot, and mouth disease caused by EV-A71: A longitudinal cohort study in Zhengzhou during 2017-2019. EBIOMEDICINE, 68. doi:10.1016/j.ebiom.2021.103398DOI: 10.1016/j.ebiom.2021.103398
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England (Journal article)
Volz, E., Mishra, S., Chand, M., Barrett, J. C., Johnson, R., Geidelberg, L., . . . Ferguson, N. M. (2021). Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. NATURE, 593(7858), 266-+. doi:10.1038/s41586-021-03470-xDOI: 10.1038/s41586-021-03470-x
COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium., Ahern, D., Ai, Z., Ainsworth, M., Allan, C., Allcock, A., . . . Zurke, Y. -X. (2021). A blood atlas of COVID-19 defines hallmarks of disease severity and specificity. doi:10.1101/2021.05.11.21256877DOI: 10.1101/2021.05.11.21256877
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies (Journal article)
Collier, D. A., De Marco, A., Ferreira, I. A. T. M., Meng, B., Datir, R. P., Walls, A. C., . . . Gupta, R. K. (2021). Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. NATURE, 593(7857), 136-+. doi:10.1038/s41586-021-03412-7DOI: 10.1038/s41586-021-03412-7
Graham, M. S., Sudre, C. H., May, A., Antonelli, M., Murray, B., Varsaysky, T., . . . Ourselin, S. (2021). Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study. LANCET PUBLIC HEALTH, 6(5), E335-E345. doi:10.1016/S2468-2667(21)00055-4DOI: 10.1016/S2468-2667(21)00055-4
Brown, L., Byrne, R. L., Fraser, A., Owen, S. I., Cubas-Atienzar, A. I., Williams, C. T., . . . Adams, E. R. (2021). Self-sampling of capillary blood for SARS-CoV-2 serology. SCIENTIFIC REPORTS, 11(1). doi:10.1038/s41598-021-86008-5DOI: 10.1038/s41598-021-86008-5
Ogbe, A., Kronsteiner, B., Skelly, D. T., Pace, M., Brown, A., Adland, E., . . . Dunachie, S. (2021). T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses. NATURE COMMUNICATIONS, 12(1). doi:10.1038/s41467-021-21856-3DOI: 10.1038/s41467-021-21856-3
Gupta, R. K., Harrison, E. M., Ho, A., Docherty, A. B., Knight, S. R., van Smeden, M., . . . Noursadeghi, M. (2021). Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study. LANCET RESPIRATORY MEDICINE, 9(4), 349-359. doi:10.1016/S2213-2600(20)30559-2DOI: 10.1016/S2213-2600(20)30559-2
Townsend, A., Rijal, P., Xiao, J., Tan, T. K., Huang, K. -Y. A., Schimanski, L., . . . Joly, E. (2021). A haemagglutination test for rapid detection of antibodies to SARS-CoV-2. NATURE COMMUNICATIONS, 12(1). doi:10.1038/s41467-021-22045-yDOI: 10.1038/s41467-021-22045-y
Sigfrid, L., Drake, T., Pauley, E., Jesudason, E., Olliaro, P., Lim, W. S., . . . ISARIC4C investigators. (2021). Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. doi:10.1101/2021.03.18.21253888DOI: 10.1101/2021.03.18.21253888
Setiabudi, W., Hungerford, D., Subramaniam, K., Vaselli, N. M., Shaw, V. E., Wilton, M., . . . French, N. (2021). Prospective observational study of SARS-CoV-2 infection, transmission and immunity in a cohort of households in Liverpool City Region, UK (COVID-LIV): a study protocol. BMJ Open, 11(3), e048317. doi:10.1136/bmjopen-2020-048317DOI: 10.1136/bmjopen-2020-048317
Thwaites, R. S., Sanchez Sevilla Uruchurtu, A., Siggins, M. K., Liew, F., Russell, C. D., Moore, S. C., . . . ISARIC4C investigators. (2021). Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19.. Science Immunology, 6(57). doi:10.1126/sciimmunol.abg9873DOI: 10.1126/sciimmunol.abg9873
Sigfrid, L., Cevik, M., Jesudason, E., Lim, W. S., Rello, J., Amuasi, J., . . . Scott, J. T. (2021). What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol.. BMJ Open, 11(3), e043887. doi:10.1136/bmjopen-2020-043887DOI: 10.1136/bmjopen-2020-043887
Pairo-Castineira, E., Clohisey, S., Klaric, L., Bretherick, A. D., Rawlik, K., Pasko, D., . . . Baillie, J. K. (2021). Genetic mechanisms of critical illness in COVID-19. NATURE, 591(7848), 92-+. doi:10.1038/s41586-020-03065-yDOI: 10.1038/s41586-020-03065-y
Garrod, G., Owen, S., Baillie, K., Baldwin, L., Brown, L., Byrne, R., . . . ISARIC4C Investigators. (2021). Comparative evaluation of ten lateral flow immunoassays to detect SARS-CoV-2 antibodies. doi:10.12688/wellcomeopenres.16522.1DOI: 10.12688/wellcomeopenres.16522.1
Bhogal, T., Khan, U. T., Lee, R., Stockdale, A., Hesford, C., Potti-Dhananjaya, V., . . . Palmieri, C. (2021). Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort.. Leukemia & lymphoma, 1-16. doi:10.1080/10428194.2021.1876865DOI: 10.1080/10428194.2021.1876865
Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre prospective cohort study (the SIREN study), England: June to November 2020 (Preprint)
DOI: 10.1101/2021.01.13.21249642
Leonhard, S. E., Halstead, S., Lant, S. B., de Albuquerque, M. D. F. P. M., de Brito, C. A. A., de Albuquerque, L. B. B., . . . Ferreira, M. L. B. (2021). Guillain-Barre syndrome during the Zika virus outbreak in Northeast Brazil: An observational cohort study. JOURNAL OF THE NEUROLOGICAL SCIENCES, 420. doi:10.1016/j.jns.2020.117272DOI: 10.1016/j.jns.2020.117272
Leclerc, Q., Fuller, N., Keogh, R., Diaz-Ordaz, K., Sekula, R., Semple, M., . . . CMMID COVID-19 Working Group. (2021). Importance of patient bed pathways and length of stay differences in predicting COVID-19 bed occupancy in England. doi:10.1101/2021.01.14.21249791DOI: 10.1101/2021.01.14.21249791
Liang, L., Cheng, Y., Li, Y., Shang, Q., Huang, J., Ma, C., . . . Yu, H. (2021). Long-term neurodevelopment outcomes of hand, foot and mouth disease inpatients infected with EV-A71 or CV-A16, a retrospective cohort study. EMERGING MICROBES & INFECTIONS, 10(1), 545-554. doi:10.1080/22221751.2021.1901612DOI: 10.1080/22221751.2021.1901612
T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously SARS-CoV-2-Infected and Infection-Naive UK Healthcare Workers: A Multicentre, Prospective, Observational Cohort Study (Preprint)
DOI: 10.2139/ssrn.3820576
2020
Docherty, A., Mulholland, R., Lone, N., Cheyne, C., De Angelis, D., Diaz-Ordaz, K., . . . for ISARIC4C investigators. (2020). Changes in UK hospital mortality in the first wave of COVID-19: the ISARIC WHO Clinical Characterisation Protocol prospective multicentre observational cohort study. doi:10.1101/2020.12.19.20248559DOI: 10.1101/2020.12.19.20248559
Lee, R. J., Zhou, C., Wysocki, O., Shotton, R., Tivey, A., Lever, L., . . . Armstrong, A. C. (2020). Establishment of CORONET; COVID-19 Risk in Oncology Evaluation Tool to identify cancer patients at low versus high risk of severe complications of COVID-19 infection upon presentation to hospital. doi:10.1101/2020.11.30.20239095DOI: 10.1101/2020.11.30.20239095
Song, C., Zhou, Y., Li, Y., Liang, L., Turtle, L., Wang, F., . . . Yu, H. (2020). Enterovirus genomic load and disease severity among children hospitalised with hand, foot and mouth disease. EBIOMEDICINE, 62. doi:10.1016/j.ebiom.2020.103078DOI: 10.1016/j.ebiom.2020.103078
A systematic evaluation of IgM and IgG antibody assay accuracy in diagnosing acute Zika Virus infection in Brazil; lessons relevant to emerging infections (Preprint)
DOI: 10.1101/2020.11.25.399386
ISARIC Clinical Characterisation Group. (2020). COVID-19 symptoms at hospital admission vary with age and sex: ISARIC multinational study.. medRxiv. doi:10.1101/2020.10.26.20219519DOI: 10.1101/2020.10.26.20219519
Thomson, E., Rosen, L., Shepherd, J., Spreafico, R., da Silva Filipe, A., Wojcechowskyj, J., . . . the COVID-19 Genomics UK (COG-UK) consortium. (2020). The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity. doi:10.1101/2020.11.04.355842DOI: 10.1101/2020.11.04.355842
Peng, Y., Mentzer, A. J., Liu, G., Yao, X., Yin, Z., Dong, D., . . . Investigators, I. (2020). Broad and strong memory CD4(+)and CD8(+)T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. NATURE IMMUNOLOGY, 21(11), 1336-1345. doi:10.1038/s41590-020-0782-6DOI: 10.1038/s41590-020-0782-6
Geretti, A. M., Stockdale, A. J., Kelly, S. H., Cevik, M., Collins, S., Waters, L., . . . Semple, M. G. (2020). Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK): a prospective observational study.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. doi:10.1093/cid/ciaa1605DOI: 10.1093/cid/ciaa1605
Townsend, A., Rijal, P., Xiao, J., Tan, T. K., Huang, K. -Y., Schimanski, L., . . . Joly, E. (2020). A haemagglutination test for rapid detection of antibodies to SARS-CoV-2. doi:10.21203/rs.3.rs-91353/v2DOI: 10.21203/rs.3.rs-91353/v2
Clark, J., Penrice-Randal, R., Sharma, P., Kipar, A., Dong, X., Pennington, S., . . . Stewart, J. (2020). Sequential infection with influenza A virus followed by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to more severe disease and encephalitis in a mouse model of COVID-19. doi:10.1101/2020.10.13.334532DOI: 10.1101/2020.10.13.334532
Moore, S. C., Penrice-Randal, R., Alruwaili, M., Randle, N., Armstrong, S., Hartley, C., . . . Hiscox, J. A. (2020). Amplicon-Based Detection and Sequencing of SARS-CoV-2 in Nasopharyngeal Swabs from Patients With COVID-19 and Identification of Deletions in the Viral Genome That Encode Proteins Involved in Interferon Antagonism. VIRUSES-BASEL, 12(10). doi:10.3390/v12101164DOI: 10.3390/v12101164
Gupta, R., Harrison, E., Ho, A., Docherty, A., Knight, S., van Smeden, M., . . . Noursadeghi, M. (2020). Development and validation of the 4C Deterioration model for adults hospitalised with COVID-19. doi:10.1101/2020.10.09.20209957DOI: 10.1101/2020.10.09.20209957
Thwaites, R., Sevilla Uruchurtu, A. S., Siggins, M., Liew, F., Russell, C., Moore, S., . . . Openshaw, P. J. M. (2020). Elevated antiviral, myeloid and endothelial inflammatory markers in severe COVID-19. doi:10.1101/2020.10.08.20209411DOI: 10.1101/2020.10.08.20209411
Andersson, M. I., Arancibia-Carcamo, C. V., Auckland, K., Baillie, J. K., Barnes, E., Beneke, T., . . . Zambon, M. (2020). SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus.. Wellcome open research, 5, 181. doi:10.12688/wellcomeopenres.16002.2DOI: 10.12688/wellcomeopenres.16002.2
Townsend, A., Rijal, P., Xiao, J., Tan, T. K., Huang, K. -Y., Schimanski, L., . . . Joly, E. (2020). A haemagglutination test for rapid detection of antibodies to SARS-CoV-2. doi:10.1101/2020.10.02.20205831DOI: 10.1101/2020.10.02.20205831
Brito Ferreira, M. L., Pessoa Militao de Albuquerque, M. D. F., Antunes de Brito, C. A., de Oliveira Franca, R. F., Porto Moreira, A. J., de Morais Machado, M. I., . . . Solomon, T. (2020). Neurological disease in adults with Zika and chikungunya virus infection in Northeast Brazil: a prospective observational study. LANCET NEUROLOGY, 19(10), 826-839. doi:10.1016/S1474-4422(20)30232-5DOI: 10.1016/S1474-4422(20)30232-5
Pairo-Castineira, E., Clohisey, S., Klaric, L., Bretherick, A., Rawlik, K., Parkinson, N., . . . The Covid-19 Human Genetics Initiative. (2020). Genetic mechanisms of critical illness in Covid-19. doi:10.1101/2020.09.24.20200048DOI: 10.1101/2020.09.24.20200048
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. (Journal article)
Knight, S. R., Ho, A., Pius, R., Buchan, I., Carson, G., Drake, T. M., . . . ISARIC4C investigators. (2020). Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score.. BMJ: British Medical Journal, 370. doi:10.1136/bmj.m3339DOI: 10.1136/bmj.m3339
Sigfrid, L., Cevik, M., Jesudason, E., Lim, W. S., Rello, J., Amuasi, J. H., . . . Scott, J. (2020). What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? - A harmonised, global longitudinal observational study. doi:10.1101/2020.08.26.20180950DOI: 10.1101/2020.08.26.20180950
Swann, O., Holden, K., Turtle, L., Pollock, L., Fairfield, C., Drake, T., . . . ISARIC Coronavirus Clinical Characterisation Consortium (ISARIC4C) Investigators. (2020). Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. BMJ, 370. doi:10.1136/bmj.m3249DOI: 10.1136/bmj.m3249
Geretti, A. M., Stockdale, A., Kelly, S., Cevik, M., Collins, S., Waters, L., . . . Group, C. H. A. S. E. S. (2020). Outcomes of COVID-19 Related Hospitalisation Among People with HIV in the ISARIC WHO Clinical Characterisation Protocol UK Protocol: Prospective Observational Study. doi:10.2139/ssrn.3666248DOI: 10.2139/ssrn.3666248
Zheng, X., Yu, X., Wang, Y., Turtle, L., Cui, M., Wang, R., & Yin, C. (2020). Complete protection for mice conferred by a DNA vaccine based on the Japanese encephalitis virus P3 strain used to prepare the inactivated vaccine in China. VIROLOGY JOURNAL, 17(1). doi:10.1186/s12985-020-01400-3DOI: 10.1186/s12985-020-01400-3
Millar, J., Neyton, L., Seth, S., Dunning, J., Merson, L., Murthy, S., . . . ISARIC-4C Investigators. (2020). Robust, reproducible clinical patterns in hospitalised patients with COVID-19. doi:10.1101/2020.08.14.20168088DOI: 10.1101/2020.08.14.20168088
Patterson, E. I., Prince, T., Anderson, E. R., Casas-Sanchez, A., Smith, S. L., Cansado-Utrilla, C., . . . Hughes, G. L. (2020). Methods of inactivation of SARS-CoV-2 for downstream biological assays.. The Journal of infectious diseases. doi:10.1093/infdis/jiaa507DOI: 10.1093/infdis/jiaa507
Geretti, A., Stockdale, A., Kelly, S., Villa, G., Turtle, L., Semple, M., & Sabin, C. (2020). Outcomes of COVID-19 related hospitalisation among people with HIV in the ISARIC WHO Clinical Characterisation Protocol (UK): a prospective observational study. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 23, 13-14. Retrieved from https://www.webofscience.com/
Knight, S., Ho, A., Pius, R., Buchan, I., Carson, G., Drake, T., . . . Harrison, E. (2020). Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. doi:10.1101/2020.07.30.20165464DOI: 10.1101/2020.07.30.20165464
Andersson, M., Arancibia-Carcamo, C., Auckland, K., Baillie, K., Barnes, E., Beneke, T., . . . Zambon, M. (2020). SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus. doi:10.12688/wellcomeopenres.16002.1DOI: 10.12688/wellcomeopenres.16002.1
ISARIC Clinical Characterisation Group., Baillie, K., Baruch, J., Beane, A., Blumberg, L., Bozza, F. A., . . . Merson, L. (2020). ISARIC COVID-19 Clinical Data Report: Final report January 2020 – January 2023. doi:10.1101/2020.07.17.20155218DOI: 10.1101/2020.07.17.20155218
Swann, O., Holden, K., Turtle, L., Pollock, L., Fairfield, C., Drake, T., . . . Semple, M. (2020). Clinical characteristics of children and young people hospitalised with covid-19 in the United Kingdom: prospective multicentre observational cohort study. doi:10.1101/2020.07.14.20153320DOI: 10.1101/2020.07.14.20153320
Turtle, L. (2020). Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2. JOURNAL OF MEDICAL VIROLOGY, 92(7), 705-706. doi:10.1002/jmv.25828DOI: 10.1002/jmv.25828
Harrison, E., Docherty, A., Barr, B., Buchan, I., Carson, G., Drake, T., . . . Investigators, I. (2020). Ethnicity and Outcomes from COVID-19: The ISARIC CCP-UK Prospective Observational Cohort Study of Hospitalised Patients. doi:10.2139/ssrn.3618215DOI: 10.2139/ssrn.3618215
Wang, R., Zhen, Z., Turtle, L., Hou, B., Li, Y., Wu, N., . . . An, J. (2020). T cell immunity rather than antibody mediates cross-protection against Zika virus infection conferred by a live attenuated Japanese encephalitis SA14-14-2 vaccine.. Applied microbiology and biotechnology. doi:10.1007/s00253-020-10710-zDOI: 10.1007/s00253-020-10710-z
Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel [version 1; peer review: 2 approved] (Journal article)
Adams, E. R., Ainsworth, M., Anand, R., Andersson, M. I., Auckland, K., Baillie, J. K., . . . Whitehouse, J. (2020). Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel [version 1; peer review: 2 approved]. Wellcome Open Research, 5. doi:10.12688/wellcomeopenres.15927.1DOI: 10.12688/wellcomeopenres.15927.1
Peng, Y., Mentzer, A. J., Liu, G., Yao, X., Yin, Z., Dong, D., . . . Dong, T. (2020). Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients.. bioRxiv. doi:10.1101/2020.06.05.134551DOI: 10.1101/2020.06.05.134551
Andersson, M., Arancibia-Cárcamo, C., Auckland, K., Baillie, K., Barnes, E., Beneke, T., . . . Zambon, M. (2020). SARS-CoV-2 RNA detected in blood samples from patients with COVID-19 is not associated with infectious virus. doi:10.1101/2020.05.21.20105486DOI: 10.1101/2020.05.21.20105486
Palmieri, C., Palmer, D., Openshaw, P. J., Baille, J. K., Semple, M. G., & Turtle, L. (2020). Cancer datasets and the SARS-CoV-2 pandemic: establishing principles for collaboration.. ESMO Open, 5(3). doi:10.1136/esmoopen-2020-000825DOI: 10.1136/esmoopen-2020-000825
Methods of inactivation of SARS-CoV-2 for downstream biological assays. (Journal article)
Patterson, E. I., Prince, T., Anderson, E. R., Casas-Sanchez, A., Smith, S. L., Cansado-Utrilla, C., . . . Hughes, G. L. (2020). Methods of inactivation of SARS-CoV-2 for downstream biological assays.. bioRxiv : the preprint server for biology. doi:10.1101/2020.05.21.108035DOI: 10.1101/2020.05.21.108035
National COVID Testing Scientific Advisory Panel., Adams, E., Ainsworth, M., Anand, R., Andersson, M., Auckland, K., . . . Whitehouse, J. (2020). Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel. doi:10.1101/2020.04.15.20066407DOI: 10.1101/2020.04.15.20066407
Subramaniam, K. S., Lant, S., Goodwin, L., Grifoni, A., Weiskopf, D., & Turtle, L. (2020). Two Is Better Than One: Evidence for T-Cell Cross-Protection Between Dengue and Zika and Implications on Vaccine Design.. Frontiers in Immunology, 11, 517. doi:10.3389/fimmu.2020.00517DOI: 10.3389/fimmu.2020.00517
Moore, S., Penrice-Randal, R., Alruwaili, M., Dong, X., Pullan, S., Carter, D., . . . Hiscox, J. (2020). Amplicon based MinION sequencing of SARS-CoV-2 and metagenomic characterisation of nasopharyngeal swabs from patients with COVID-19. doi:10.1101/2020.03.05.20032011DOI: 10.1101/2020.03.05.20032011
Cross-Protection Against Zika Virus Infection Conferred by a Live Attenuated Japanese Encephalitis SA14-14-2 Vaccine (Preprint)
DOI: 10.1101/2020.02.14.950352
Andersson, M., Arancibia-Carcamo, C., Auckland, K., Baillie, K., Barnes, E., Beneke, T., . . . Zambon, M. (2020). SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus. doi:10.12688/wellcomeopenres.16002.2DOI: 10.12688/wellcomeopenres.16002.2
2019
Turtle, L., Easton, A., Defres, S., Ellul, M., Bovill, B., Hoyle, J., . . . Solomon, T. (2019). 'More than devastating'-patient experiences and neurological sequelae of Japanese encephalitis. JOURNAL OF TRAVEL MEDICINE, 26(7). doi:10.1093/jtm/taz064DOI: 10.1093/jtm/taz064
Wingfield, T., Dearden, L., Calvert, P., Osanlou, O., Johnston, B., Chawla, A., . . . Wenstone, R. (2019). Adenovirus Type 7 causing severe lower respiratory tract infection in immunocompetent adults: a comparison of two contrasting cases from an intensive care unit in North West England.. Clinical infection in practice, 2, 100007. doi:10.1016/j.clinpr.2019.100007DOI: 10.1016/j.clinpr.2019.100007
Malawian Malaise (Chapter)
Turtle, L., & Kneen, R. (2019). Malawian Malaise. In Case Studies in Neurological Infections of Adults and Children (pp. 265-268). Cambridge University Press. doi:10.1017/9781139628839.062DOI: 10.1017/9781139628839.062
Two Types of Shaking (Chapter)
Turtle and Gemma Buxton, L. (2019). Two Types of Shaking. In Case Studies in Neurological Infections of Adults and Children (pp. 255-259). Cambridge University Press. doi:10.1017/9781139628839.060DOI: 10.1017/9781139628839.060
Turtle, L. C. W. (n.d.). Low population Japanese encephalitis virus (JEV) seroprevalence in Udayapur district, Nepal, three years after a JE vaccination programme: a case for further catch up campaigns?. PLoS Neglected Tropical Diseases, 13. doi:10.1371/journal.pntd.0007269DOI: 10.1371/journal.pntd.0007269
2018
Wingfield, T., Ball, R., Woolley, S. D., Campbell, F., Heath, R. M., Beeching, N. J., & Turtle, L. (2018). Closing The Brief Case: A Rare Case of Invasive Amebiasis Requiring Emergency Subtotal Colectomy in an HIV-Positive Man.. Journal of clinical microbiology, 56(8), e01704-e01717. doi:10.1128/jcm.01704-17DOI: 10.1128/jcm.01704-17
Wingfield, T., Ball, R., Woolley, S. D., Campbell, F., Heath, R. M., Beeching, N. J., & Turtle, L. (2018). The Brief Case: A Rare Case of Invasive Amebiasis Requiring Emergency Subtotal Colectomy in an HIV-Positive Man. JOURNAL OF CLINICAL MICROBIOLOGY, 56(8). doi:10.1128/JCM.01703-17DOI: 10.1128/JCM.01703-17
Turtle, L., & Solomon, T. (2018). Japanese encephalitis - the prospects for new treatments. Nature Reviews Neurology, 14(5), 298-313. doi:10.1038/nrneurol.2018.30DOI: 10.1038/nrneurol.2018.30
Poonsiri, T., Wright, G. S. A., Diamond, M. S., Turtle, L., Solomon, T., & Antonyuk, S. V. (2018). Structural study of the C-terminal domain of non-structural protein 1 from Japanese encephalitis virus. Journal of Virology, 92(7). doi:10.1128/jvi.01868-17DOI: 10.1128/jvi.01868-17
Mehta, R., Soares, C. N., Medialdea-Carrera, R., Ellul, M., Texeira da Silva, M. T., Rosala-Hallas, A., . . . Solomon, T. (2018). The spectrum of neurological disease associated with Zika and chikungunya viruses in adults in Rio de Janeiro, Brazil: A case series. PLoS Neglected Tropical Diseases, 12(2). doi:10.1371/journal.pntd.0006212DOI: 10.1371/journal.pntd.0006212
2017
Grifoni, A., Pham, J., Sidney, J., O'Rourke, P. H., Paul, S., Peters, B., . . . Sette, A. (2017). Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans. JOURNAL OF VIROLOGY, 91(24). doi:10.1128/JVI.01469-17DOI: 10.1128/JVI.01469-17
Grifoni, A., Angelo, M. A., Lopez, B., O'Rourke, P. H., Sidney, J., Cerpas, C., . . . Weiskopf, D. (2017). Global Assessment of Dengue Virus-Specific CD4+ T Cell Responses in Dengue-Endemic Areas. Frontiers in Immunology, 8. doi:10.3389/fimmu.2017.01309DOI: 10.3389/fimmu.2017.01309
Turtle, L. C. W., Tatullo, F., Bali, T., Ravi, V., Soni, M., Chan, S., . . . Solomon, T. (2017). Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/dengue Co- Endemic Area. PLoS Neglected Tropical Diseases, 11(01), 23 pages. doi:10.1371/journal.pntd.0005263DOI: 10.1371/journal.pntd.0005263
Haloprogin (Chapter)
Ramos-Martín, V., & Hope, W. (2017). Haloprogin. In Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition (pp. 2933-2935). doi:10.1201/9781315152110DOI: 10.1201/9781315152110
2016
Turtle, L., Bali, T., Buxton, G., Chib, S., Chan, S., Soni, M., . . . Solomon, T. (2016). Human T cell responses to Japanese encephalitis virus in health and disease. Journal of Experimental Medicine, 213(7), 1331-1352. doi:10.1084/jem.20151517DOI: 10.1084/jem.20151517
2015
An integrated model of care for neurological infections: the first six years of referrals to a specialist service at a university teaching hospital in Northwest England (Journal article)
Turtle, L., Jung, A., Beeching, N. J., Cocker, D., Davies, G. R., Nicolson, A., . . . Solomon, T. (2015). An integrated model of care for neurological infections: the first six years of referrals to a specialist service at a university teaching hospital in Northwest England. BMC INFECTIOUS DISEASES, 15. doi:10.1186/s12879-015-1109-3DOI: 10.1186/s12879-015-1109-3
A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal (vol 10, e0122608, 2015) (Journal article)
Rayamajhi, A., Nightingale, S., Bhatta, N. K., Singh, R., Ledger, E., Bista, K. P., . . . Solomon, T. (2015). A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal (vol 10, e0122608, 2015). PLOS ONE, 10(8). doi:10.1371/journal.pone.0136008DOI: 10.1371/journal.pone.0136008
A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal (Journal article)
Rayamajhi, A., Nightingale, S., Bhatta, N. K., Singh, R., Ledger, E., Bista, K. P., . . . Solomon, T. (2015). A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal. PLOS ONE, 10(4). doi:10.1371/journal.pone.0122608DOI: 10.1371/journal.pone.0122608
Turtle, L., McGill, F., Bettridge, J., Matata, C., Christley, R., & Solomon, T. (2015). A Survey of UK Healthcare Workers’ Attitudes on Volunteering to Help with the Ebola Outbreak in West Africa. PLoS ONE, 10(3). doi:10.1371/journal.pone.0120013DOI: 10.1371/journal.pone.0120013
2014
A case of iatrogenic adrenal suppression after co-administration of cobicistat and fluticasone nasal drops (Journal article)
Lewis, J., Turtle, L., Khoo, S., & Nsutebu, E. (2014). A case of iatrogenic adrenal suppression after co-administration of cobicistat and fluticasone nasal drops. AIDS, 28(17), 2636-2637. doi:10.1097/QAD.0000000000000462DOI: 10.1097/QAD.0000000000000462
EBOLA CRISIS What stops healthcare workers volunteering to fight Ebola in west Africa? (Journal article)
Solomon, T., Turtle, L., McGill, F., Matata, C., & Christley, R. (2014). EBOLA CRISIS What stops healthcare workers volunteering to fight Ebola in west Africa?. BMJ-BRITISH MEDICAL JOURNAL, 349. doi:10.1136/bmj.g6443DOI: 10.1136/bmj.g6443
Encephalitis, Viral (Chapter)
Turtle, L., & Solomon, T. (2014). Encephalitis, Viral. In Encyclopedia of the Neurological Sciences (pp. 20-24). Elsevier. doi:10.1016/b978-0-12-385157-4.00375-4DOI: 10.1016/b978-0-12-385157-4.00375-4
Japanese encephalitis virus infection (Chapter)
Griffiths, M. J., Turtle, L., & Solomon, T. (2014). Japanese encephalitis virus infection. In NEUROVIROLOGY (Vol. 123, pp. 561-576). Retrieved from https://www.webofscience.com/
2013
Innate Immune Mechanisms in Japanese Encephalitis Virus Infection: Effect on Transcription of Pattern Recognition Receptors in Mouse Neuronal Cells and Brain Tissue (Journal article)
Fadnis, P. R., Ravi, V., Desai, A., Turtle, L., & Solomon, T. (2013). Innate Immune Mechanisms in Japanese Encephalitis Virus Infection: Effect on Transcription of Pattern Recognition Receptors in Mouse Neuronal Cells and Brain Tissue. VIRAL IMMUNOLOGY, 26(6), 366-377. doi:10.1089/vim.2013.0016DOI: 10.1089/vim.2013.0016
Japanese Encephalitis Virus Infection (Chapter)
Turtle, L., & Solomon, T. (2013). Japanese Encephalitis Virus Infection. In Viral Infections of the Human Nervous System (pp. 271-293). Springer Basel. doi:10.1007/978-3-0348-0425-7_11DOI: 10.1007/978-3-0348-0425-7_11
2012
In routine UK hospital practice T-SPOT.TB™ is useful in some patients with a modest pre-test probability of active tuberculosis (Journal article)
Turtle, L., Kemp, T., Davies, G. R., Squire, S. B., Beeching, N. J., & Beadsworth, M. B. J. (2012). In routine UK hospital practice T-SPOT.TB™ is useful in some patients with a modest pre-test probability of active tuberculosis. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 23(4), 363-367. doi:10.1016/j.ejim.2012.01.002DOI: 10.1016/j.ejim.2012.01.002
In routine UK hospital practice T-SPOT.TB™ is useful in some patients with a modest pre-test probability of active tuberculosis. (Journal article)
Turtle, L., Kemp, T., Davies, G. R., Squire, S. B., Beeching, N. J., & Beadsworth, M. B. J. (2012). In routine UK hospital practice T-SPOT.TB™ is useful in some patients with a modest pre-test probability of active tuberculosis.. European journal of internal medicine, 23(4), 363-367. doi:10.1016/j.ejim.2012.01.002DOI: 10.1016/j.ejim.2012.01.002
Encephalitis caused by flaviviruses (Journal article)
Turtle, L., Griffiths, M. J., & Solomon, T. (2012). Encephalitis caused by flaviviruses. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 105(3), 219-223. doi:10.1093/qjmed/hcs013DOI: 10.1093/qjmed/hcs013
Encephalitis caused by flaviviruses. (Journal article)
Turtle, L., Griffiths, M. J., & Solomon, T. (2012). Encephalitis caused by flaviviruses.. QJM., 105(3), 219-223. doi:10.1093/qjmed/hcs013DOI: 10.1093/qjmed/hcs013
2011
Turtle, L., Vyakernam, R., Menon-Johansson, A., Nelson, M. R., & Soni, N. (2011). Intensive Care Usage by HIV-Positive Patients in the HAART Era.. Interdisciplinary perspectives on infectious diseases, 2011, 847835. doi:10.1155/2011/847835DOI: 10.1155/2011/847835
'Septrin psychosis' among renal transplant patients with <i>Pneumocystis jirovecii</i> pneumonia (Journal article)
Walker, L. E., Thomas, S., McBride, C., Howse, M., Turtle, L. C. W., Vivancos, R., . . . Beadsworth, M. B. J. (2011). 'Septrin psychosis' among renal transplant patients with <i>Pneumocystis jirovecii</i> pneumonia. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 66(5), 1117-1119. doi:10.1093/jac/dkr050DOI: 10.1093/jac/dkr050
'Septrin psychosis' among renal transplant patients with Pneumocystis jirovecii pneumonia. (Journal article)
Walker, L. E., Thomas, S., McBride, C., Howse, M., Turtle, L. C. W., Vivancos, R., . . . Beadsworth, M. B. J. (2011). 'Septrin psychosis' among renal transplant patients with Pneumocystis jirovecii pneumonia.. The Journal of antimicrobial chemotherapy, 66(5), 1117-1119. doi:10.1093/jac/dkr050DOI: 10.1093/jac/dkr050
2009
An evaluation of the usefulness of neuroimaging for the diagnosis of Japanese encephalitis (Journal article)
Dung, N. M., Turtle, L., Chong, W. K., Mai, N. T., Thao, T. T., Thuy, T. T., . . . Solomon, T. (2009). An evaluation of the usefulness of neuroimaging for the diagnosis of Japanese encephalitis. JOURNAL OF NEUROLOGY, 256(12), 2052-2060. doi:10.1007/s00415-009-5249-5DOI: 10.1007/s00415-009-5249-5
Severe pneumonia caused by ciprofloxacin resistant panton-valentine leukocidin producing community acquired meticillin resistant <i>Staphylococcus aureus</i> (Journal article)
Turtle, L., Wey, E., & James, E. (2009). Severe pneumonia caused by ciprofloxacin resistant panton-valentine leukocidin producing community acquired meticillin resistant <i>Staphylococcus aureus</i>. JOURNAL OF INFECTION, 58(1), 86-87. doi:10.1016/j.jinf.2008.10.008DOI: 10.1016/j.jinf.2008.10.008
2008
Tics, Twitches, Tales: The Experiences of Gilles de la Tourette's Syndrome (Journal article)
Turtle, L., & Robertson, M. M. (2008). Tics, Twitches, Tales: The Experiences of Gilles de la Tourette's Syndrome. AMERICAN JOURNAL OF ORTHOPSYCHIATRY, 78(4), 449-455. doi:10.1037/a0014329DOI: 10.1037/a0014329
2007
Medical emergencies in human immunodeficiency virus infected patients (Journal article)
Turtle, L. (2007). Medical emergencies in human immunodeficiency virus infected patients. Current Anaesthesia & Critical Care, 18(2), 94-106. doi:10.1016/j.cacc.2007.03.004DOI: 10.1016/j.cacc.2007.03.004
2003
Urocortin protects cardiac myocytes from ischemia/reperfusion injury by attenuating calcium insensitive phospholipase A<sub>2</sub> gene expression (Journal article)
Lawrence, K. M., Scarabelli, T. M., Turtle, L., Chanalaris, A., Townsend, P. A., Carroll, C. J., . . . Latchman, D. S. (2003). Urocortin protects cardiac myocytes from ischemia/reperfusion injury by attenuating calcium insensitive phospholipase A<sub>2</sub> gene expression. FASEB JOURNAL, 17(13), 2313-+. doi:10.1096/fj.02-0832fjeDOI: 10.1096/fj.02-0832fje
Undated
Poor Antibody Responses to SARS-CoV-2 Infection or Vaccination Are Associated With High Re-Infection Rates in Haemodialysis and Renal Transplant Patients (Journal article)
Shankar, S., Beckett, J., Tipton, T., Ogbe, A., Kasanyinga, M., Dold, C., . . . Klenerman, P. (n.d.). Poor Antibody Responses to SARS-CoV-2 Infection or Vaccination Are Associated With High Re-Infection Rates in Haemodialysis and Renal Transplant Patients.
Sustained T Cell Immunity, Protection and Boosting Using Extended Dosing Intervals of BNT162b2 mRNA Vaccine (Journal article)
Payne, R. P., Longet, S., Austin, J. A., Skelly, D., Dejnirattisai, W., Adele, S., . . . Consortium, T. P. I. T. C. H. (n.d.). Sustained T Cell Immunity, Protection and Boosting Using Extended Dosing Intervals of BNT162b2 mRNA Vaccine.
T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously SARS-CoV-2-Infected and Infection-Naive UK Healthcare Workers: A Multicentre, Prospective, Observational Cohort Study (Journal article)
Angyal, A., Longet, S., Moore, S., Payne, R. P., Harding, A., Tipton, T., . . . Group, P. I. T. C. H. C. (n.d.). T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously SARS-CoV-2-Infected and Infection-Naive UK Healthcare Workers: A Multicentre, Prospective, Observational Cohort Study.